New Otitis media study reports, "the antihistamine-decongestant prescription was found to significantly influence both the duration of nasal congestion and the course of middle ear effusion."



Kantrex kanamycin sulfate capsules

Type of Work:
Print or label
Registration Number / Date:
TX0000212223 / 1979-02-27
Date of Publication:
May 31, 1978
Date of Creation:
1977
Title:
Kantrex kanamycin sulfate capsules : equivalent to 500 milligrams.
Application Title:
Kantrex label.
Imprint:
Syracuse, N. Y. : Bristol Laboratories, c1977.
Description:
Sticker.
Other Title:
Kantrex label
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Cancer

Copyrights records by Bristol-Myers Company. Bristol Laboratories

Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Head and neck cancer

Copyrights records by Bristol Laboratories, division of Bristol-Myers Company.

Your Bristol sales career

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0000259328 / 1979-03-02
Date of Publication:
May 26, 1978
Date of Creation:
1978
Title:
Your Bristol sales career : selling the science of medicine.
Imprint:
Syracuse, N. Y. : Bristol Laboratories, c1978.
Description:
1 v.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Mutamycin, mitomycin for injection
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Head and neck cancer

Adrenocortical carcinoma patient report

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0000981515 / 1982-09-07
Date of Publication:
May 31, 1980
Date of Creation:
1980
Title:
Adrenocortical carcinoma patient report.
Imprint:
Syracuse, N. Y. : Bristol Laboratories, c1980.
Description:
7 p.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Non-Hodgkin's lymphomas
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Outpatient anesthesia & analgesia

Management of Platinol toxicities cisplatin

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0000999960 / 1982-10-01
Date of Publication:
July 31, 1981
Date of Creation:
1981
Title:
Management of Platinol toxicities cisplatin : a round-table discussion.
Description:
23 p.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Lung cancer
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Cardiovascular disease

Doctor Watson's notebook

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001005522 / 1982-11-12
Date of Publication:
September 1, 1982
Date of Creation:
1982
Title:
Doctor Watson's notebook : the case for Bufferin c codeine number 3.
Imprint:
Syracuse, N. Y. : Bristol, c1982.
Description:
32 p.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Cancer
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Non-Hodgkin's lymphomas

Don't see much "resistant staph"? Take a closer look

Type of Work:
Print or label
Registration Number / Date:
TX0001010540 / 1982-11-04
Date of Publication:
May 1, 1982
Date of Creation:
1982
Title:
Don't see much "resistant staph"? Take a closer look.
Description:
Folder.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Authorship on Application:
text and photos.: Bristol Laboratories, division of Bristol-Myers Company, employer for hire.
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Cardiovascular disease
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: In surgical prophylaxis

Pallace (megestrol acetate) product information overview

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001013159 / 1982-11-01
Date of Publication:
May 1, 1982
Date of Creation:
1982
Title:
Pallace (megestrol acetate) product information overview.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Pancreatic cancer
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Induction chemotherapy for head and neck cancers

Symptomatic treatment for respiratory congestion in the nineteenth century could be a draining experience

Type of Work:
Print or label
Registration Number / Date:
TX0001013778 / 1982-11-01
Date of Publication:
July 1, 1982
Date of Creation:
1982
Title:
Symptomatic treatment for respiratory congestion in the nineteenth century could be a draining experience.
Application Title:
Naldecon--keeper visual aid: symptomatic treatment for respiratory congestion in the nineteenth century could be a draining experience.
Other Title:
Naldecon--keeper visual aid
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Disseminated bladder cancer
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: In surgical prophylaxis

The Salutensin (hydroflumethiazide 50 mg/reserpine 0.125 mg) national hypertension quiz

Type of Work:
Print or label
Registration Number / Date:
TX0001013934 / 1982-11-08
Date of Publication:
August 1, 1982
Date of Creation:
1982
Title:
The Salutensin (hydroflumethiazide 50 mg/reserpine 0.125 mg) national hypertension quiz.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Hypertension therapy
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Lung cancer

Pallace (megestrol acetate) in the management of recurrent breast cancer

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001014266 / 1982-11-15
Date of Publication:
August 2, 1982
Date of Creation:
1982
Title:
Pallace (megestrol acetate) in the management of recurrent breast cancer : a round-table discussion.
Description:
26 p.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Non-Hodgkin's lymphomas
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Cardiovascular disease

Ultracef (cefadroxil monohydrate)

Type of Work:
Print or label
Registration Number / Date:
TX0001032409 / 1982-09-03
Date of Publication:
September 30, 1982
Date of Creation:
1982
Title:
Ultracef (cefadroxil monohydrate)
Description:
51 p.
Other Title:
Ultracef B.I.D., everything you expect a new generation oral cephalosporin to be.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Notes:
Cover ti.: Ultracef B. I. D., everything you expect a new generation oral cephalosporin to be.
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Hypertension therapy
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Hypertension and Salutensin

The Essential component in combination antibiotic therapy

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001034228 / 1982-12-06
Date of Publication:
August 31, 1982
Date of Creation:
1982
Title:
The Essential component in combination antibiotic therapy : amikacin sulfate, Amikin synergy, the antibiotic-combination safety net.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Authorship on Application:
collective work: Bristol Laboratories, division of Bristol-Myers Company, employer for hire.
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Non-Hodgkin's lymphomas
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Hypertension and Salutensin

New Otitis media study reports, "the antihistamine-decongestant prescription was found to significantly influence both the duration of nasal congestion and the course of middle ear effusion."

Type of Work:
Print or label
Registration Number / Date:
TX0001046489 / 1983-01-03
Date of Publication:
July 30, 1982
Date of Creation:
1982
Title:
New Otitis media study reports, "the antihistamine-decongestant prescription was found to significantly influence both the duration of nasal congestion and the course of middle ear effusion."
Variant title:
New Otitis media study reports, "the antihistamine-decongestant prescription was found to significantly influence
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Outpatient anesthesia & analgesia
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Non-Hodgkin's lymphomas

Platinol cisplatin

Type of Work:
Print or label
Registration Number / Date:
TX0001054417 / 1983-01-19
Date of Publication:
May 27, 1982
Date of Creation:
1982
Title:
Platinol cisplatin : proven efficacy in treating a variety of cancers.
Variant title:
Platinol cisplatin : proven efficacy in treating a variety of cancers
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Cancer
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Cardiovascular disease

Hodgkin's disease

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001235693 / 1983-09-06
Date of Publication:
May 31, 1983
Date of Creation:
1983
Title:
Hodgkin's disease : update 1983, Alternatives to M O P P and salvage chemotherapy.
Number of similar titles:
14
Similar Title:
Hodgkin's disease
Variant title:
Hodgkin's disease : update 1983
Other Title:
Alternatives to M O P P and salvage chemotherapy
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Notes:
Cataloged from appl. only.
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Cancer
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Pancreatic cancer

Recognizing and managing pulmonary toxicity associated with Blenoxane (sterile bleomycin sulfate)

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001375204 / 1984-07-02
Date of Publication:
May 31, 1984
Date of Creation:
1984
Title:
Recognizing and managing pulmonary toxicity associated with Blenoxane (sterile bleomycin sulfate) : update 1984.
Variant title:
Recognizing and managing pulmonary toxicity associated with Blenoxane (sterile bleomycin sulfate) : update 1984.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Notes:
Cataloged from appl. only.
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Hypertension therapy
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Induction chemotherapy for head and neck cancers

Can your choice of empiric antimicrobial therapy minimize development of resistance?

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001375785 / 1984-07-05
Date of Publication:
May 31, 1983
Date of Creation:
1983
Title:
Can your choice of empiric antimicrobial therapy minimize development of resistance?
Application Title:
Amikin: empiric microbial therapy, no. 1.
Description:
1 v. + 2 p. in folder.
Other Title:
Avoiding emergence of resistant strains, a multicenter surveillance study
Challenges in empiric therapy: no. 1
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Notes:
Includes Challenges in empiric therapy: no. 1, Avoiding emergence of resistant strains, a multicenter surveillance study.
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Non-Hodgkin's lymphomas
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Outpatient anesthesia & analgesia

Platinol (cisplatin for injection) clinical experience overview update

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001389897 / 1984-07-09
Date of Publication:
September 30, 1983
Date of Creation:
1983
Title:
Platinol (cisplatin for injection) clinical experience overview update.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Notes:
Cataloged from appl.
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Mutamycin, mitomycin for injection
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: In surgical prophylaxis

Noninvasive bladder cancer

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001390232 / 1984-07-09
Date of Publication:
September 30, 1983
Date of Creation:
1983
Title:
Noninvasive bladder cancer : the current approach to diagnosis and treatment.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Notes:
Cataloged from appl.
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: In surgical prophylaxis
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Pancreatic cancer

Platinol (cisplatin for injection) ready reference for cancer-treating professionals

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001390289 / 1984-08-02
Date of Publication:
May 31, 1984
Date of Creation:
1984
Title:
Platinol (cisplatin for injection) ready reference for cancer-treating professionals.
Description:
42 p.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Outpatient anesthesia & analgesia
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Cardiovascular disease

The Bristol veterinary handbook of antimicrobial therapy

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001393456 / 1984-08-21
Date of Publication:
January 31, 1983
Date of Creation:
1983
Date in Notice:
notice: 1982
Title:
The Bristol veterinary handbook of antimicrobial therapy / Dudley E. Johnston, editor.
Imprint:
[s.l. : s.n.], c1982.
Description:
224 p.
Number of similar titles:
1
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Authorship on Application:
collective work: Bristol Laboratories, division of Bristol-Myers Company, employer for hire.
Names:
Dudley E. Johnston

Copyrights records by Johnston, Dudley E.

Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Disseminated bladder cancer
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Outpatient anesthesia & analgesia

An Oncology update

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001394398 / 1984-08-02
Date of Publication:
November 30, 1983
Date of Creation:
1983
Title:
An Oncology update : the dynamics of antibiotic synergy in the compromised host.
Variant title:
An Oncology update : the dynamics of antibiotic synergy in the compromised host.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Notes:
Cataloged from appl. only.
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Induction chemotherapy for head and neck cancers
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Mutamycin, mitomycin for injection

Can your choice of empiric antimicrobial therapy meet the needs of compromised patients?

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001394666 / 1984-08-02
Date of Publication:
January 31, 1984
Date of Creation:
1984
Title:
Can your choice of empiric antimicrobial therapy meet the needs of compromised patients?
Application Title:
Amikin.
Series:
Challenges in empiric therapy ; no. 3
Description:
Kit.
Other Title:
Challenges in empiric therapy ; no. 3
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Ovarian cancer
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Cancer

Naldecon-CX suspension

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001394930 / 1984-08-02
Date of Publication:
January 31, 1984
Date of Creation:
1984
Date in Notice:
notice: 1983
Title:
Naldecon-CX suspension : when a dog of a cough accompanies an adult cold!
Application Title:
Naldecon X--cough/cold formula comparator.
Other Title:
Naldecon X--cough/cold formula comparator
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Hypertension therapy
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Cardiovascular disease

Practical approaches to the safe handling of anticancer products

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001462799 / 1984-12-10
Date of Publication:
August 31, 1984
Date of Creation:
1984
Title:
Practical approaches to the safe handling of anticancer products : proceedings of a symposium, Mayaguez, Puerto Rico, November 2-5, 1983.
Imprint:
Chicago : Education Division of Sieber & McIntyre, c1984.
Description:
29 p.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Hypertension therapy
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Cardiovascular disease

VePesid (etoposide [VP-16-213]) injection

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001467623 / 1984-12-10
Date of Publication:
August 31, 1984
Date of Creation:
1984
Title:
VePesid (etoposide [VP-16-213]) injection : clinical experience overview.
Application Title:
VePesid: clinical experience overview.
Description:
68 p.
Variant title:
VePesid (etoposide [VP-16-213]) injection : clinical experience overview
Other Title:
VePesid: clinical experience overview
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Non-Hodgkin's lymphomas
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Head and neck cancer

VePesid

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001472547 / 1984-12-10
Date of Publication:
August 31, 1984
Date of Creation:
1984
Title:
VePesid : ready reference for cancer-treating professionals.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Notes:
Cataloged from appl.
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Non-Hodgkin's lymphomas
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Induction chemotherapy for head and neck cancers

Mutamycin (mitomycin for injection), clinical experience overview

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001547691 / 1985-04-10
Date of Publication:
January 31, 1985
Date of Creation:
1985
Title:
Mutamycin (mitomycin for injection), clinical experience overview : update 1985.
Application Title:
Mutamycin, clinical experience overview: update 1985.
Description:
72 p.
Variant title:
Mutamycin (mitomycin for injection), clinical experience overview : update 1985.
Other Title:
Mutamycin, clinical experience overview: update 1985.
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Disseminated bladder cancer
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Cardiovascular disease

Platinol (cisplatin for injection)

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001549023 / 1985-04-10
Date of Publication:
January 31, 1985
Date of Creation:
1985
Title:
Platinol (cisplatin for injection) : clinical experience overview : update 1985.
Application Title:
Platinol: clinical experience overview: update 1985.
Description:
96 p.
Number of similar titles:
4
Other Title:
Platinol: clinical experience overview: update 1985
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Copyright Notice:
notice: Bristol-Meyers, Oncology Division
Authorship on Application:
collective work: Bristol Laboratories, division of Bristol-Meyers Company, employer for hire.
Names:
Bristol-Meyers. Oncology Division
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Non-Hodgkin's lymphomas
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: In surgical prophylaxis

Stadol

Type of Work:
Non-dramatic literary work
Registration Number / Date:
TX0001790440 / 1986-03-31
Date of Publication:
September 30, 1985
Date of Creation:
1985
Title:
Stadol : anesthesia & analgesia for outpatient surgery & diagnosis (dosage and administration reference)
Variant title:
Stadol : anesthesia & analgesia for outpatient surgery & diagnosis (dosage and administration reference)
Copyright Claimant:
Bristol Laboratories, division of Bristol-Myers Company
Notes:
Cataloged from appl.
Names:
Bristol-Myers Company. Bristol Laboratories (101 documents)
example document: Disseminated bladder cancer
Bristol Laboratories, division of Bristol-Myers Company. (67 documents)
example document: Hypertension and Salutensin
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible. Multiple persons can share the same name.